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High-throughput technologies have enabled the systematic identification and characterization of
most, or possibly all, of the components governing segmentation in the fruit fly Drosophila. What
have we learned?
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One of the most intensively studied processes in animal
development is the division of the embryonic Drosophila
epidermis (ectoderm) into visible segments, a process that
lays the foundations for the segmented structure of the adult
insect. Segmentation is governed by a program of sequential
gene expression that is one of the best-defined genetic
cascades in animal development [1]. It is put into motion by
three maternal gene regulatory proteins - Bicoid, Hunchback
and Caudal - which specify an initial ‘pre-segmentation’
pattern along the anterior-posterior axis, while the anterior
and posterior ends of the body are specified independently
by the localized activation of the maternal receptor tyrosine
kinase Torso. The principal target genes of these maternal
factors in the embryo’s genome are known as gap genes, as
their lack leads to gaps in the body pattern. The gap genes,
such as Krüppel, Knirps and Giant, encode sequence-specific
transcriptional repressors. The interplay of the maternal
factors and the gap repressors constitutes one of the leading
paradigms for the combinatorial control of gene expression
in development. These regulatory factors bind to the enhan-
cers of the segmentation genes to produce precisely
positioned on/off repeating transverse stripes of expression
for each gene, foreshadowing the subdivision of the embryo
into a repeating series of body segments. The segmentation
genes typically have highly complex enhancers, with
multiple binding sites for each gene regulatory protein.
Detailed descriptions of individual parts of the Drosophila
segmentation process have been available for many years,
but Segal and colleagues [2] have recently taken a systems
approach to segmentation by developing a comprehensive
quantitative thermodynamics-based model in an attempt to
describe the regulation of segmentation-gene expression in
the early embryo. This analysis was made possible by two
recent advances in understanding Drosophila segmentation.
First, computational and experimental methods have identi-
fied a total of 44 different enhancers that respond to distinct
combinations of maternal and gap transcription factors to
direct precisely localized bands and stripes of gap and seg-
mentation gene expression in the early Drosophila embryo
[3-6]. Second, quantitative high-resolution imaging of the
distribution profiles of each maternal and gap protein has
provided precise information about the relative concentra-
tions of these critical regulators in each nucleus of the embryo
at key points during the progressive refinement of stripe
formation [7,8]. Each enhancer contains a specific constella-
tion of binding sites for maternal and gap proteins, and within
each nucleus there is a particular combination of trans-
criptional activators and repressors that can bind to these sites.
Using this information, Segal et al. devised a two-component
model to predict the expression, or output, mediated by each
of the 44 known gap gene and segmentation gene enhancers
[2]. The model incorporates some of the features used in
previous site-occupancy models - such models predict the
occupancy of each binding site by its corresponding trans-
cription factor for a given gene and position in the embryo
(for example, see [9-11]). The first component of the Segal
model is a Boltzmann weight function (which will predict the
probability that a binding site is occupied at a given concen-
tration of transcription factor), which is computed for every
sequence match to a known binding motif within a given
enhancer. The second component of the model is a function
that defines the transcriptional output, which depends onthe ratio of predicted activator and repressor binding sites
occupied. Higher occupancy of the activator sites is predicted
to produce expression at a particular location within the
embryo, whereas greater occupancy of the repressor sites is
predicted to produce little or no expression.
So how well did the Segal model perform? Using three
parameters (concentration scaling, self-cooperativity binding
strength and the expression contribution) for each input
maternal and gap transcription factor, the model is in
general agreement with the gene-expression patterns
attributable to the enhancers in the gap genes, but produces
only variable agreement with the stripes of gene expression
produced by enhancers in the genes known as pair-rule
genes, segmentation genes that are expressed in stripes in
alternating ‘segments’ along the anterior-posterior axis. For
many of these latter enhancers, there is only a weak corre-
lation between the relative number of activator and repres-
sor binding sites, the nuclear concentrations of the corres-
ponding input transcription factors, and the experimentally
observed output gene expression levels. For such enhancers,
a more accurate picture means invoking ‘nonlinear’
mechanisms of transcriptional regulation, such as hetero-
typic cooperative DNA-binding interactions between differ-
ent types of activators, repression by quenching (where the
binding of a repressor protein appears to prevent activation
of the gene by an activator bound at a nearby site) and
significant contributions of low-affinity binding sites to the
control of gene expression. Indeed, cooperative DNA
binding and quenching have proved critical for the accurate
modeling of the dorsal-ventral patterning network [10].
Cooperative binding, quenching and the importance of low-
affinity binding sites are well documented in the ‘pre-
systems’ literature. Numerous studies have established the
importance of cooperative DNA binding of Bicoid in gene
activation [12-14]. Repression by quenching has been shown
in the prototypic stripe 2 enhancer that directs the localized
expression of the pair-rule gene eve. Although Bicoid-binding
activator sites overlap Giant- and Krüppel-binding repressor
sites in this enhancer [15,16], both Giant and Krüppel are able
to inhibit expression even when bound as much as 50-100 bp
away from the closest activator sites [17,18]. This quenching
is mediated by a co-repressor protein, CtBP, which is
recruited to the DNA through interactions with a simple
peptide motif, PxDSxK/R, present in the Krüppel, Giant and
Knirps gap repressor proteins [19-21]. The eve stripe 2
enhancer contains a total of five Bicoid activator sites, three
of which are low-affinity sites [22]. The analysis of natural
populations of Drosophila led to the hypothesis that these
low-affinity sites provide an intrinsic mechanism for ensuring
the robustness of gene expression and enabling the
modification of expression patterns during evolution [23,24].
The earlier molecular studies that established these princi-
ples were restricted to the analysis of just a handful of
enhancers. Segal et al. [2] have now provided evidence that
the mechanisms determined previously through traditional
molecular studies are prevalent and generally applicable to
the entirety of the segmentation process. Indeed, establish-
ing the generality of known mechanisms is one of the great
promises of systems biology.
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